Critical Illness Cover: Which Conditions Are Actually Covered in 2026

A Brief History of Critical Illness Cover

Critical illness insurance was invented in South Africa in 1983 by cardiac surgeon Dr Marius Barnard, who had observed that his patients survived their operations only to face financial ruin during recovery. The concept was straightforward: a lump sum payment on diagnosis of a defined serious illness, regardless of whether the policyholder could return to work.

The product arrived in the UK market in the mid-1980s and grew rapidly through the 1990s and 2000s. In 1999, the Association of British Insurers (ABI) first published a Statement of Best Practice with standardised model definitions for the core conditions — an important step that gave policyholders a baseline for comparing products. These definitions have been updated several times since (the Statement of Best Practice was replaced by the ABI Guide to Minimum Standards for Critical Illness Cover, the current version of which was published in 2022 and updated in 2023), and most UK insurers follow them as a floor, adding enhanced or extended definitions on top.

By 2026, critical illness cover is a well-established product, but it remains one of the most complex in the protection market. The devil is consistently in the definitions.

---

Core Conditions: Covered by Virtually All Policies

The following conditions appear on almost every critical illness policy and are covered under standard definitions:

Cancer — specified severity (see important caveats below)

Heart attack — with or without specific clinical criteria (again, definitions vary — see below)

Stroke — with permanent neurological deficit of specified duration; temporary strokes (TIA — transient ischaemic attack) are typically excluded

Coronary artery bypass surgery — for the treatment of coronary artery disease

Kidney failure — requiring permanent dialysis or transplant

Major organ transplant — heart, lung, liver, kidney, pancreas, or bone marrow

Motor neurone disease — resulting in permanent symptoms

Multiple sclerosis — with persisting symptoms; some policies require a confirmed neurologist's diagnosis

Total blindness — permanent and irreversible loss of sight in both eyes; single-eye loss may be a partial payment

Total deafness — permanent and irreversible loss of hearing in both ears

Loss of speech — permanent loss of ability to produce recognisable speech

Coma — of specified severity and duration (typically 96 hours with certain clinical criteria)

Loss of limbs — permanent loss of use of two or more limbs (single limb loss is often a partial payment)

Benign brain tumour — resulting in specified neurological symptoms; the definition of "benign" and required symptoms varies

Aortic aneurysm surgery — for aneurysm requiring surgery with median sternotomy or thoracotomy

Parkinson's disease — with permanent symptoms before a specified age (typically 60 or 65)

Alzheimer's disease/dementia — resulting in permanent cognitive impairment; some policies are more restrictive in definition than others

These conditions form the core of any CI policy. If a policy does not include all of these at a meaningful level, it should be regarded as a stripped-down or budget product.

---

The Cancer Nuances: Where Claims Disputes Concentrate

Cancer is by far the most common cause of critical illness claims — accounting for approximately 60–65% of all CI claims in UK data. It is also the area where policy definitions most often determine the difference between a paid and a declined claim.

Non-Melanoma Skin Cancer

The great majority of critical illness policies exclude basal cell carcinoma and squamous cell carcinoma (the non-melanoma skin cancers) entirely or subject them to strict limitations. This is because these cancers are extremely common, very rarely fatal, and highly treatable. Malignant melanoma is typically covered.

Carcinoma In Situ

Carcinoma in situ refers to abnormal cells that have not yet invaded surrounding tissue — a very early stage of cancer development. The ABI model definition for cancer typically requires the cancer to have "invaded" surrounding tissue; pure carcinoma in situ is therefore outside the main definition.

However, many policies include specific carcinoma in situ provisions as partial payment benefits — typically paying 20–25% of the sum assured for specified types, such as ductal carcinoma in situ (DCIS) of the breast or carcinoma in situ of the cervix.

DCIS of the Breast

Ductal carcinoma in situ of the breast is a relatively common diagnosis affecting tens of thousands of women each year in the UK. Whether it is covered under a specific CI policy, and at what payment level, is a significant practical question for women's CI cover. Some policies include DCIS under the main cancer definition; others restrict it to a partial payment; others exclude it entirely. This single definition can have a material effect on the practical value of the policy.

Low-Grade Prostate Cancer

Prostate cancer exists on a wide spectrum of severity. Some very low-grade prostate cancers — particularly those managed by "active surveillance" rather than treatment — are excluded from some CI policies, on the basis that they do not represent a serious threat to life. The specific Gleason score or TNM staging thresholds used in the policy definition determine coverage. Men buying CI cover should check the prostate cancer definition specifically.

Testicular Cancer

Testicular cancer is the most common cancer in men aged 15–35 in the UK. Most cases are highly curable, but the treatment is serious — typically involving surgery, chemotherapy, and/or radiotherapy. Testicular cancer is generally covered under the main cancer definition in most policies, but early-stage diagnoses with high TNM staging may fall into grey areas. As with prostate cancer, the specific staging criteria in the policy definition matter.

---

The Heart Attack Definition: Myocardial Necrosis and the Troponin Question

The standard ABI model definition for heart attack requires myocardial necrosis (death of heart muscle cells) as a result of inadequate blood supply to part of the heart. In practice, this means the diagnosis must be confirmed by a cardiologist using specific clinical criteria — which historically included ECG changes and/or raised cardiac enzymes.

The widespread adoption of high-sensitivity troponin testing in A&E and cardiology settings in the 2010s created a new problem: many patients now receive a "non-ST elevation myocardial infarction" (NSTEMI) or even a "type 2 MI" diagnosis based primarily on troponin elevation alone, without the other criteria that older CI definitions required.

Some policy definitions have been updated to reflect modern diagnostic practice. Others have not. This means that two patients admitted to hospital with chest pain, both leaving with an MI diagnosis on their discharge summary, could have very different outcomes when claiming on their CI policies — depending on the specific wording used when the policy was written.

This is not a marginal issue. It affects a material number of CI claims. If you hold a legacy CI policy written before approximately 2015, it may be worth reviewing the heart attack definition specifically.

---

Extended and Comprehensive Conditions

Beyond the core list, policies increasingly compete on the breadth of their additional conditions. These fall into two broad tiers:

Extended Critical Illness Policies (40–60 Conditions)

These add conditions such as:

• Third-degree burns covering a specified percentage of body surface
• HIV infection from a blood transfusion or medical procedure
• Crohn's disease of specified severity
• Systemic lupus erythematosus (SLE) with specified complications
• Aplastic anaemia
• Bacterial meningitis resulting in permanent symptoms
• Cerebral abscess

Comprehensive Critical Illness Policies (60–80+ Conditions)

The top-tier products in the UK market — typically from providers such as Legal & General, Aviva, AIG, and Zurich in the UK — now list 80+ conditions, including many rare but serious diseases. Adding breadth to the list matters mainly if you are concerned about a condition outside the core set — perhaps due to family history.

The Partial Payment Layer

Many comprehensive policies include a separate tier of "additional" or "partial payment" conditions, which pay a smaller benefit — typically £25,000 or 25% of the sum assured, whichever is lower — on diagnosis of less severe conditions. Common partial payment conditions include:

• Angioplasty (coronary balloon angioplasty)
• Carcinoma in situ of specified types
• Single limb loss below a specified point
• Pacemaker insertion
• Early-stage cancer not meeting the main definition

Partial payments typically do not reduce the main sum assured, meaning a full claim can still be made later. They provide valuable financial support without exhausting the main benefit.

---

Comparing Policies: The Definition Problem

A common mistake when shopping for critical illness cover is comparing policies on the basis of price or the number of conditions listed. Neither metric reliably predicts whether a claim will be paid.

The only meaningful comparison is of the actual definitions. For the conditions most likely to affect you — based on your age, sex, family history, and health status — read the specific policy wording and compare it to competitor definitions.

Specific questions to ask:

• Does the cancer definition include or exclude DCIS of the breast?
• What cardiac criteria must be met for a heart attack claim?
• Is Parkinson's or Alzheimer's covered, and from what age?
• Are partial payments available for angioplasty or carcinoma in situ?
• Does the stroke definition require permanent neurological deficit, and for how long?

This level of policy analysis is difficult for most consumers to conduct independently. Specialist protection advisers who deal with CI claims regularly — not just policy sales — have practical knowledge of which insurers pay promptly and which dispute marginal claims.

---

Children's Critical Illness Cover

Most CI policies designed for adults include an element of children's critical illness cover — typically covering a defined list of conditions for dependent children up to a specified age, with a lower benefit cap (often £25,000 or 50% of the adult sum assured). This is a valuable addition, covering conditions specific to children such as cerebral palsy, cystic fibrosis, and specified childhood cancers.

The conditions and definitions for children's CI cover can vary significantly between policies. Families with young children should check this section of any policy carefully.

---

How Global Investments Can Help

Understanding critical illness insurance definitions requires more than reading a policy summary — it requires detailed knowledge of how insurers apply their definitions at claim stage, which is very different from how they are marketed at point of sale.

Global Investments works with specialist protection advisers who:

• Analyse the specific conditions most relevant to your circumstances based on health history and family background
• Compare full policy definitions across the leading CI providers, not just headline condition counts
• Identify gaps in existing cover — legacy policies with outdated definitions are common
• Structure CI cover alongside income protection, life assurance, and medical insurance as part of a coordinated protection plan
• For international clients, source CI products from Isle of Man or other offshore providers that are appropriate for non-UK residents

Critical illness cover, properly structured with the right definitions in place, can be one of the most valuable financial protection tools available. The difference between a claim paid and a claim declined often comes down to a single paragraph of policy wording. Getting that right from the outset is what specialist advice is for.

The information in this guide is for general educational purposes and does not constitute financial advice. Policy definitions and coverage vary — always read the full policy terms and seek independent professional advice.